Development of oral solid dosage forms presents numerous challenges to formulators. These range from development studies to achieve startup formulation, speed and simplicity in process design, scale-up, and cost considerations. In this session we will present a digital tool for predicting a startup formulation along with recommendations for optimal drug-excipient combinations. In order to facilitate faster formulation development and speed to market, a new direct compression excipient will also be introduced. Approaches to taste masking solutions in oral solid dosage forms using novel film forming polymer will be discussed. Challenges and opportunities in the development of oral controlled release formulations using hot melt extrusion 3D printing technology will also be discussed. Contributions from both Industry and Academia will be structured in four targeted presentations followed by Q&A sessions. Time Title and Presenters 9:00AM – 9:05AM Introduction and Moderator: Sandip Tiwari, BASF 9:05AM - 9:25AM Digital Assistant to Support Product Development. Presenter: Ferdinand Brandl, BASF 9:25AM – 9:45AM ZoomLab™ Aided Formulation Development of an Immediate Release Tablet Presenter: Thorsten Cech, BASF 9:45AM – 10:55AM Live Q&A 10:55AM – 11:00AM Break 10:00AM - 10:05AM Introduction and Moderator: Sandip Tiwari, BASF 10:05AM – 10:25AM Hot melt extrusion and filament fabrication 3D printing. Presenter: Suresh Bandari, Univ. Mississippi 10:25AM – 10:45AM Taste masking and moisture protection for oral solid dosage forms using novel polymer. Presenter: Krizia Karry, BASF 10:45AM – 11:00AM Live Q&A
Taste masking properties and analytical methods to overcome challenges in oral solid formulations
Controlled release formulations using hot melt extrusion 3D printing technology
The use of novel, modern digital tools in formulation design with recommendations for optimal drug-excipient combinations.